Journal of Clinical Medicine (Feb 2021)

The Effect of Transoesophageal Echocardiography on Treatment Change in a High-Volume Stroke Unit

  • Camille Siegel,
  • Benjamin Marchandot,
  • Kensuke Matsushita,
  • Antonin Trimaille,
  • Corina Mirea,
  • Marilou Peillex,
  • François Sauer,
  • Cecile How-Choong,
  • Floriane Zeyons,
  • Olivier Rouyer,
  • Annie Trinh,
  • Helene Petit-Eisenmann,
  • Laurence Jesel,
  • Patrick Ohlmann,
  • Valérie Wolff,
  • Olivier Morel

DOI
https://doi.org/10.3390/jcm10040805
Journal volume & issue
Vol. 10, no. 4
p. 805

Abstract

Read online

Background and purpose—current guidelines recommend the use of transesophageal echocardiography (TEE) in relation to cardio-embolic sources of stroke. Methods—by using an hospital-based cohort, we retrospectively analyzed consecutive patients with acute ischemic stroke (AIS), acute hemorrhagic stroke (AHS) and transient ischemic attack (TIA) who were admitted in Strasbourg Stroke Center, France between November 2017 to December 2018. TEE reports were screened for detection of potential cardiac sources of embolism and the subsequent change in medical management. We performed univariate and multivariate analyses to identify predictors of relevant TEE findings. Results-out of the 990 patients admitted with confirmed stroke, 432 patients (42.6%) underwent TEE. Patients with TEE were younger (62.8 ± 14.8 vs. 73.8, p p Rankin Scale (1 IQR (0–1) vs. 1 (0–3), p p p = 0.01), previous TIA (HR: 7.830, CI 95% 2214 to 27,689; p = 0.001) and superficial middle cerebral artery territory infarction (HR: 2.774, CI 95% 1.168–6.589; p = 0.021) were strong independent predictors with change in medical management following TEE. Conclusions—additional TEE changed the medical course of stroke patients in 7.1% in a French high-volume stroke unit.

Keywords